-
First international consultation on nocturia sheds light on neglected disease area
inAn international congress has been established by a panel of world leading experts to educate urologists and GPs about the neglected disease area called Nocturia. Nocturia means waking to urinate more than once a night regularly…
0 -
5-ASAs/mesalazine May Lower Colorectal Cancer Risk in Inflammatory Bowel Disease (IBD)
inMore evidence that taking your medication does a body good: Results of a recent study from the UK suggests that Inflammatory Bowel Disease patients (IBD) who take their 5-ASA/mesalazine medicine…
-
Ferring Pharmaceuticals and Beth Israel Deaconess Medical Center Announce Drug Discovery Collaboration Agreement
inCOPENHAGEN, DK. and BOSTON, MASS. — Ferring Pharmaceuticals and Beth Israel Deaconess Medical Center (BIDMC) today announced they have signed a collaborative agreement to…
-
Ferring and Johnson & Johnson Join in a Research Collaboration
inFerring announced today that it will collaborate with Ortho-McNeil Pharmaceuticals Inc. (Ortho-McNeil) and Ortho-McNeil’s research affiliate, Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD)…
-
Ferring appoints new Board member
inThe Board of Directors of Ferring announced this week that Professor Michael Rosenblatt has been appointed to the Group Board…
-
Ferring Appoints New Vice-President of Global Marketing
inFerring would like to announce that Mr. Aaron Graff has been appointed as Vice President of Global Marketing, Medical Services and Business Development…
-
Taking the Needle Out of the Injection
inFerring Launches a New No Needle Device at 2nd Ferring International Paediatric Endocrinology Symposium…
-
Ferring Appoints New Board Member
inThe Board of Directors of Ferring announced today that Mr. Bernd Wolff has been appointed as a board member. Wolff becomes an outside director to the board…
-
FDA APPROVES BRAVELLE™ (urofollitropin for injection, purified)
inFerring Pharmaceuticals, a world leader in naturally occurring protein hormones, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Bravelle™…
-
Building for the 21st Century
inThe new Ferring International Center in Copenhagen will be officially inaugurated by the Danish Minister for Science, Technology and Innovation and renowned architect Henning Larsen on Thursday, March 21st, 2002…
Uncategorized
Uncategorized